medigoxin - CISMeF

Preferred Label : medigoxin;

MeSH definition : A semisynthetic digitalis glycoside with the general properties of DIGOXIN but more rapid onset of action. Its cardiotonic action is prolonged by its demethylation to DIGOXIN in the liver. It has been used in the treatment of congestive heart failure (HEART FAILURE).;

MeSH synonym : 4''' o methyldigoxin; 4'''-o-methyldigoxin; beta-methyldigoxin; beta methyldigoxin; Metildigoxin;

CISMeF synonym : metildigoxine; kern brand of medigoxin; roche brand of medigoxin;

MeSH Hyperonym : methyldigoxin;

MeSH hyponym : bemecor; medixin; lanirapid; lanitop;

MeSH CAS label : Card-20(22)-enolide, 3-((O-2,6-dideoxy-4-O-methyl-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-;

MeSH Related Number : 30685-43-9 (Medigoxin);

Registry Number MeSH : 30685-43-9;

Wikipedia link : https://en.wikipedia.org/wiki/Metildigoxin;

Codes EINECS : 250-292-0;

Is substance : O;

UNII : I7GG1YUC5V;

InChIKey : IYJMSDVSVHDVGT-PEQKVOOWSA-N;

Details

Origin ID

D008520;

UMLS CUI

C0025132;

ATC code(s)
- metildigoxin [ATC Code]
ATC code(s)
- metildigoxin [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- metildigoxin [Substance BNPC]
Pharmacological action(s)
- anti-arrhythmia agents [MeSH Descriptor]
- cardiotonic agents [MeSH Descriptor]
- enzyme inhibitors [MeSH Descriptor]
Record concept(s)
- bemecor [MeSH concept]
- lanirapid [MeSH concept]
- lanitop [MeSH concept]
- medigoxin [MeSH concept]
- medixin [MeSH concept]
- methyldigoxin [MeSH concept]
See also inter- (CISMeF)
- Metildigoxin [SMS substance]
- Product containing metildigoxin (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Metildigoxin [ICD-11 Extension code]
- Metildigoxin [NCIt concept]
- Metildigoxin (substance) [SNOMED CT concept]
- Product containing metildigoxin (medicinal product) [SNOMED CT concept]
- metildigoxin [ATC Code]
- metildigoxin [Substance BNPC]
Validated automatic mappings to BTNT
- metildigoxin [ATC Code]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients